@rabbidead92
Active 1 year, 3 months ago
roteins and thus single transporter expression systems might lead to over- or underestimation of drug-drug interactions.The introduction of anti-CD20 monoclonal antibodies such as rituximab, ofatumumab, or obinutuzumab improved the therapy of B-cell malignancies even though the precise physiological role and regulation of CD20 remains unclear. […] View
-
James Harris posted an update 1 year, 3 months ago
roteins and thus single transporter expression systems might lead to over- or underestimation of drug-drug interactions.The introduction of anti-CD20 monoclonal antibodies such as rituximab, ofatumumab, or obinutuzumab improved the therapy of B-cell malignancies even though the precise physiological role and regulation of CD20 remains unclear.…[Read more]
-
James Harris became a registered member 1 year, 3 months ago
